BioLife Solutions develops, manufactures, and markets bioproduction tools and services to the cell and gene therapy industry and biopharma market. Co.'s bioproduction tools and services are comprised of three lines that contain seven main offerings: cell processing, which includes biopreservation media and human platelet lysate media, cryogenic vials, and automated cell-processing fill machines; freezers and thaw systems, which include ultra-low temperature freezers, cryogenic freezers and accessories, and automated thawing devices; and storage and cold chain services, which include biological and pharmaceutical material storage and cloud connected smart shipping containers. The BLFS stock yearly return is shown above.
The yearly return on the BLFS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the BLFS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|